The antifertility effectiveness of copper/low-density polyethylene nanocomposite and its influence on the endometrial environment in rats

Contraception

Volumn 75, Issue 2, 2007, Pages 157-161

  Liu, He fang ^a   Liu, Zi long ^a   Xie, Chang sheng ^b   Yu, Jing ^a   Zhu, Chang hong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antifertility effectiveness; Copper containing intrauterine device; Copper low density polyethylene nanocomposite; Rat; Side effect

Indexed keywords

COPPER; COPPER LOW DENSITY POLYETHYLENE NANOCOMPOSITE; POLYETHYLENE DERIVATIVE; PROSTAGLANDIN E2; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTRACEPTION; CONTROL GROUP; CONTROLLED STUDY; ENDOMETRIUM; ENVIRONMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; FERTILITY; MALE; MATING; NONHUMAN; PARAMETER; PREGNANCY; RAT; SEXUAL MATURATION; STATISTICAL SIGNIFICANCE;

ANIMALS; COPPER; DINOPROSTONE; ENDOMETRIUM; FEMALE; INTRAUTERINE DEVICES, COPPER; NANOCOMPOSITES; POLYETHYLENE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33846354925     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.09.012     Document Type: Article

References (31)

1. Burns J.W., Goodpasture J.C., Friel P., Wheeler R., and Zaneveld L.J. Development and evaluation of an inhibitor-releasing matrix for intrauterine devices. Contraception 26 (1982) 521-533
2. Tauber P.F., Kloppel A., Goodpasture J.C., Burns J., Ludwig H., and Zaneveld L.J. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices. Am J Obstet Gynecol 140 (1981) 322-328
3. Cao L., Zhou Y., Liu Z., et al. Pre-clinical experimental studies of indomethacin-releasing copper intrauterine device. J Tongji Med Univ 20 (2000) 249-252
4. Cai S.Z., Xia X.P., and Xie C.S. Corrosion behavior of copper/LDPE nanocomposites in simulated uterine solution. Biomaterials 26 (2005) 2671-2676
5. Kjaldgaard A. Uterine fibrinolysis and unilateral insertion of devices in rats. Res Exp Med (Berl) 186 (1986) 15-19
6. Johannisson E. Mechanism of action of intrauterine devices: biochemical changes. Contraception 36 (1987) 11-22
7. Spinnato II J.A. Mechanism of action of intrauterine contraceptive devices and its relation to informed consent. Am J Obstet Gynecol 176 (1997) 503-506
8. Takeuchi K., Mori A., Yamamoto S., Sonoda T., and Nagata Y. Effect of the secretions from the IUD-bearing uterus on peri-implantation mouse embryos. Contraception 41 (1990) 655-662
9. Chantler E.N. Role of copper in IUDs. IPPF Med Bull 18 (1984) 1-2
10. Mora N., Cano E., Mora E.M., and Bastidas J.M. Influence of pH and oxygen on copper corrosion in simulated uterine fluid. Biomaterials 23 (2002) 667-671
11. Patai K., Balogh I., and Szarvas Z. Clinicopathological problems of the local tissue effect of the copper-releasing intrauterine contraceptive device (IUD). I, General characteristics of the copper-containing IUD (clinical study). Acta Chir Hung 30 (1989) 129-132
12. Arancibia V., Pena C., Allen H.E., and Lagos G. Characterization of copper in uterine fluids of patients who use the copper T-380A intrauterine device. Clin Chim Acta 332 (2003) 69-78
13. Zielske H., Koch U.J., Badura R., and Ladeburg H. Studies on copper release from copper-T device (T-Cu200) and its influence on sperm migration in vitro. Contraception 10 (1974) 651-666
14. Zhang C., Xu N., and Yang B. The corrosion behavior of copper in the simulated uterine fluid. Corros Sci 38 (1996) 635-641
15. Bastidas J.M., Mora N., Cano E., and Polo J.L. Characterization of copper corrosion products originated in simulated uterine fluids and on packaged intrauterine devices. J Mater Sci Mater Med 12 (2001) 391-397
16. Bastidas D.M., Cano E., and Mora E.M. Influence of oxygen, albumin and pH on copper dissolution in a simulated uterine fluid. Eur J Contracept Reprod Health Care 10 (2005) 123-130
17. Rizk M., Shaban N., Medhat I., Moby el Dien Y., and Ollo M.A. Electron microscopic and chemical study of the deposits formed on the copper and inert IUCDs. Contraception 42 (1990) 643-653
18. O'Brien P. The effects of increasing the copper load on IUD performance: a systematic review. Eur J Contracept Reprod Health Care 9 (2004) 93
19. Sivin I., and Schmidt F. Effectiveness of IUDs: a review. Contraception 36 (1987) 55-84
20. Zipper J., Medel M., and Prager R. Suppression of fertility by intrauterine copper and zinc in rabbits. A new approach to intrauterine contraception. Am J Obstet Gynecol 105 (1969) 529-534
21. Zipper J.A., Tatum H.J., Pastene L., Medel M., and Rivera M. Metallic copper as an intrauterine contraceptive adjunct to the "T" device. Am J Obstet Gynecol 105 (1969) 1274-1278
22. Liedholm P., Srivastava K., Wingerup L., and Astedt B. Higher fibrinolytic activity in human endometrium in direct contact with an IUD. Acta Obstet Gynecol Scand 62 (1983) 169-170
23. Larsson B., Liedholm P., and Astedt B. Effect of copper and plastic intra-uterine devices on the fibrinolytic activity of the endometrium in the rat. Int J Fertil 20 (1975) 145-150
24. Larsson B., Liedholm P., and Astedt B. Increased fibrinolytic activity in the endometrium of patients using copper-IUD (Gravigard). Int J Fertil 20 (1975) 77-80
25. Larsson B., Liedholm P., Sjoberg N.O., and Astedt B. Increased fibrinolytic activity in the endometrium of patients using copper-IUD. Contraception 9 (1974) 531-537
26. Hagenfeldt K. The role of prostaglandins and allied substances in uterine haemostasis. Contraception 36 (1987) 23-35
27. R IUD on fibrinolytic activity of the endometrium in the rabbit. Contraception 19 (1979) 443-448
28. Khanna A., Biswas A.K., Dubey B., and Khanna A.K. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices. Indian J Med Res 96 (1992) 147-149
29. Hillier K., and Kasonde J.M. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device. Lancet 1 (1976) 15-16
30. Kelly R.W., and Abel M.H. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biol Reprod 28 (1983) 883-889
31. Barthwal M., and Srivastava K. Management of IUD-associated menorrhagia in female rhesus monkeys (Macaca mulatta). Adv Contracept 7 (1991) 67-76